190 related articles for article (PubMed ID: 22515143)
1. In the wake of the Mediator scandal: some progress in France, but apathy at the European level.
Prescrire Int; 2012 Apr; 21(126):110. PubMed ID: 22515143
[No Abstract] [Full Text] [Related]
2. Lessons from the Mediator scandal.
Prescrire Int; 2011 Dec; 20(122):284. PubMed ID: 22216537
[No Abstract] [Full Text] [Related]
3. New drugs and indications in 2011. France is better focused on patients' interests after the Mediator scandal, but stagnation elsewhere.
Prescrire Int; 2012 Apr; 21(126):106-10. PubMed ID: 22515141
[TBL] [Abstract][Full Text] [Related]
4. New drugs and indications in 2012. Sluggish progress, timid measures to protect patients.
Prescrire Int; 2013 Apr; 22(137):105-7. PubMed ID: 23662323
[TBL] [Abstract][Full Text] [Related]
5. Mediator scandal rocks French medical community.
Mullard A
Lancet; 2011 Mar; 377(9769):890-2. PubMed ID: 21409784
[No Abstract] [Full Text] [Related]
6. Mediator: who's to blame?
Braillon A
Lancet; 2011 Jun; 377(9782):2003-4. PubMed ID: 21665032
[No Abstract] [Full Text] [Related]
7. Mediator: who's to blame?
Waller P; Evans S
Lancet; 2011 Jun; 377(9782):2002-3. PubMed ID: 21665030
[No Abstract] [Full Text] [Related]
8. Safe drugs and the cost of good intentions.
Eichler HG; Abadie E; Raine JM; Salmonson T
N Engl J Med; 2009 Apr; 360(14):1378-80. PubMed ID: 19339718
[No Abstract] [Full Text] [Related]
9. EU directive on clinical trials penalizes small sponsors.
Meldolesi A
Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
[No Abstract] [Full Text] [Related]
10. Perseverance.
Prescrire Int; 2011 Feb; 20(113):54. PubMed ID: 21488600
[No Abstract] [Full Text] [Related]
11. European drug regulator is being investigated by fraud agency.
Kmietowicz Z
BMJ; 2011 Nov; 343():d7283. PubMed ID: 22077089
[No Abstract] [Full Text] [Related]
12. France to prosecute its drug regulator and Servier in scandal over diabetes drug.
Dyer O
BMJ; 2017 Sep; 358():j4231. PubMed ID: 28893847
[No Abstract] [Full Text] [Related]
13. [Reform Act on safety of drug and health products in France: announcement effect, strengthening or upheaval?].
Maillols-Perroy AC; Tillet Y
Therapie; 2012; 67(1):1-10. PubMed ID: 22487499
[TBL] [Abstract][Full Text] [Related]
14. "Bonne Année", "Gutes Neues Jahr"? Will 2007 be a "Happy New Year" for children's medicines in Europe?
Stephenson T
Arch Dis Child; 2007 Aug; 92(8):661-3. PubMed ID: 17642477
[TBL] [Abstract][Full Text] [Related]
15. FDA attempting to overcome major roadblocks in monitoring drug safety.
Zielinski SL
J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
[No Abstract] [Full Text] [Related]
16. The World Health Organization's prequalification program and its potential effect on data exclusivity laws.
Childs DW
Food Drug Law J; 2005; 60(1):79-97. PubMed ID: 15940855
[No Abstract] [Full Text] [Related]
17. Pharmaceuticals and medical devices: FDA oversight.
; Berry MD
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-86. PubMed ID: 22403845
[No Abstract] [Full Text] [Related]
18. [Be careful on the Internet].
Jensen JW
Ugeskr Laeger; 2006 Sep; 168(38):3189. PubMed ID: 17026889
[No Abstract] [Full Text] [Related]
19. Drug scandal exposes French regulators to public ire.
Casassus B
Nat Med; 2011 Feb; 17(2):144. PubMed ID: 21297596
[No Abstract] [Full Text] [Related]
20. [Review of the development in European Legislation on the harmonisation of the laws for medicinal products].
Lehmann B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):713-21. PubMed ID: 18584107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
